Journal
BIOLOGICS-TARGETS & THERAPY
Volume 11, Issue -, Pages 107-114Publisher
DOVE MEDICAL PRESS LTD
DOI: 10.2147/BTT.S136011
Keywords
Alzheimer's disease; acetylcholinesterase; butyryl cholinesterase; neurodegenerative; Spondias mombin
Categories
Ask authors/readers for more resources
Spondias mombin has been used in traditional medicine for the management of several diseases, including memory loss. This study aimed to evaluate the cholinesterase inhibitory activity of the methanol extract of the leaves and its derived fractions, as well as carry out detailed phytochemical investigations leading to the isolation and characterization of bioactive compounds from the plant. The acetyl cholinesterase (AChE) and butyryl cholinesterase (BUChE) inhibitory activities were evaluated by colorimetric and thin-layer chromatography bioautographic assay techniques. The ethyl acetate fraction was most active against both enzymes, with percentage inhibition of 58.10 +/- 1.08% and 52.66 +/- 1.34% against AChE and BUChE, respectively. Three compounds, namely, botulin, campesterol and phytol, with IC 50 of 0.88 mu g/mL (AChE), 4.67 mu g/mL (BuChE); 1.89 mu g/mL (AChE), 4.08 mu g/mL (BuChE) and 12.51 mu g/mL (AChE), 23.89 mu g/mL (BuChE), respectively, were isolated from the supernatant of the ethyl acetate fraction. The isolated cholinesterase inhibitory compounds correlate with the known memory-enhancing property of the plant and thus support one of its uses in ethnomedicine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available